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A B S T R A C T   
Whereas the autonomic nervous system (ANS) and the immune system used to be assigned separate functions, it 
has now become clear that the ANS and the immune system (and thereby inflammatory cascades) work closely 
together. During an acute immune response (e. g., in viral infection like Covid-19) the ANS and the immune 
system establish a fast interaction resulting in “physiological” inflammation. Based on our knowledge of the 
modulation of inflammation by the ANS we propose that a reflectory malfunction of the ANS with hyperactivity 
of the sympathetic nervous system (SNS) may be involved in the generation of acute hyperinflammation. We 
believe that sympathetic hyperactivity triggers a hyperresponsiveness of the immune system (“cytokine storm”) 
with consecutive tissue damage. These reflectory neuroimmunological and inflammatory cascades constitute a 
general reaction principle of the organism under the leadership of the ANS and does not only occur in viral 
infections, although Covid-19 is a typical current example therefore. Within the overreaction several interde-
pendent pathological positive feedback loops can be detected in which the SNS plays an important part. 
Consequently, there is a chance to regulate the hyperinflammation by influencing the SNS. This can be achieved 
by a stellate ganglion block (SGB) with local anesthetics, temporarily disrupting the pathological positive 
feedback loops. Thereafter, the complex neuroimmune system has the chance to reorganize itself. Previous 
clinical and experimental data have confirmed a favorable outcome in hyperinflammation (including pneu-
monia) after SGB (measurable e. g. by a reduction in proinflammatory cytokines).   
1. Introduction 
In viral infections, currently seen in the Covid-19 pandemic caused 
by the coronavirus SARS-CoV-2, the course is often mild, but some pa-
tients experience severe disease due to hyperresponsiveness of the im-
mune system with excessive acute inflammation (hyperinflammation, 
cytokine storm) and consecutive tissue damage. This can lead to acute 
respiratory distress syndrome (ARDS), multi-organ involvement, 
microcirculatory disturbances, and microthrombosis (Dreher et al., 
2020; Merad and Martin, 2020; Varga et al., 2020). In lab tests the so- 
called “cytokine storm”, a strong increase of cytokines (including TNF- 
α, IL-1, IL-6 and chemokines) is found (Clark and Vissel, 2017; Coper-
chini et al., 2020; Huang et al., 2020; Liu et al., 2020; Merad and Martin, 
2020; Qin et al., 2020; Ruan et al., 2020; Velavan and Meyer, 2020; Zhu 
et al., 2020). Therefore, tissue damages are not solely due to direct virus- 
induced cytopathic effects. 
The immune and inflammatory processes are – also in the case of a 
virus infection –reflectorily controlled by the autonomic nervous system 
(ANS) (Elenkov et al., 2000; Tracey, 2002; Tracey, 2009; Grebe et al., 
2010; Jänig, 2014a; Steenblock et al., 2020) which may thus be also 
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responsible for the overshooting of these processes (Steenblock et al., 
2020). In our opinion, ARDS, endothelial dysfunction, microcirculatory 
disorder, coagulopathy, are related entities during a viral infection, e. g. 
Covid-19 (Fig. 1); they are the expression of an excessive, reactive 
malfunction of the ANS, especially sympathetic hyperactivity (Bellinvia 
et al., 2020; Steenblock et al., 2020). We postulate that overreacting 
positive feedback loops on different levels of the nerve-immune- 
inflammation cascade are involved in this malfunction. Since these 
positive feedback loops are interdependent, with an important part of 
the SNS, they can be interrupted simultaneously by means of a short 
term SGB (“reset”). Interdependent positive feedback loops have the 
fundamental ability to reorganize themselves after changes of state 
(autoregulation) (Lorenz, 1972; Kluge and Neugebauer, 1994; Fischer, 
1998; Fischer, 2017). Our review shows the influence of SGB on (hyper) 
inflammation, and new aspects in the neuroimmune system based on 
positive feedback loops. 
2. Autonomic nervous system and immune system 
2.1. Anatomy and physiology of the autonomic nervous system 
The ANS (sympathetic and parasympathetic nervous system) consists 
of a central (brain and spinal cord) and peripheral part. It maintains an 
internal environment adapted to various factors. In addition, it 
significantly contributes to the control of inflammatory and immune 
processes as well as to the regulation of (micro)circulation (Elenkov 
et al., 2000; Tracey, 2002; Jänig, 2006; Jänig, 2014a). 
The ANS, by virtue of its largely ubiquitous distribution as a feedback 
autoregulatory system, influences the functions of cells and organs, 
including the vascular system, endocrine system, and immune system. 
The SNS is distributed efferently from the sympathetic centers in the 
brain, including the hypothalamus, rostral ventrolateral medulla 
(RVLM) (Ogundele et al., 2017; Paton and Spyer, 2013), through the 
spinal nucleus of the spinal cord (nucleus intermediolateralis), via the 
para- and prevertebral ganglia. The postganglionic nerve fibers run into 
the interstitium, with influence to mast cells, macrophages, fibrocytes, 
leukocytes (van der Zypen, 1967; Pischinger, 2010; Heine, 2011; Benias 
et al., 2018), and to the organs and organ systems. In addition, the 
hypothalamic-pituitary-adrenal axis (HPA) stimulates the adrenal cor-
tex, and the sympatho-adrenal (SA) system influences the adrenal me-
dulla (Jänig, 2014a). Sensory nerve fibers in the truncus sympathicus 
project from the periphery (including the interstitium) via pre- and 
paravertebral ganglia and dorsal root ganglia to the spinal cord and from 
there to the centers in the brain. A second way into the brain is via 
cervical ganglia and the vascular plexus. 
The efferent parasympathetic fibers have their origin in the core 
areas of the vagus nerve (nucleus ambiguus and nucleus dorsalis n. vagi) 
and form various plexuses together with the SNS (plexus pulmonalis, 
plexus cardiacus, and plexus coeliacus). The sensory fibers in the vagus 
nerve project into areas in the brain stem (nucleus tractus solitarius 
[NTS]). There, the NTS establishes connections to efferent para-
sympathetic and sympathetic core areas and to integration centers such 
as the hypothalamus (Ross et al., 1985; Affleck et al., 2012) (Figs. 2 and 
3). 
2.2. Neuroimmune interactions 
Whereas the nervous and the immune system were traditionally 
thought to be involved in separate functions, it has become clear since 
the works of Elenkov et al. in 2000 and Tracey in 2002 that the ANS and 
the immune system (and thereby inflammatory cascades) are in fact 
inseparable. Central networks of the ANS are informed about the pe-
ripheral inflammation and immune status (Tracey, 2002) by sensory 
nerve fibers (nociceptive neurons, sensory nerve fibers in the truncus 
sympathicus and in the vagal nerve) as well as by the humoral pathway – 
especially cytokines, which (among others) originate from the inflamed 
areas and lymphoid organs (Jänig, 2014a) (Figs. 2 and 3). Humoral and 
afferent neuronal signals co-determine the strength of the efferent 
“response” of the vagus and especially of the SNS from the autonomous 
centers of the brain (Kenney and Ganta, 2014). The ANS can control not 
only a general inflammatory and immune response, but also local pro-
cesses in the damaged tissue (with sensory feedback to the brain) (Figs. 2 
and 3). Thus, immunological homeostasis is a continuous, homeody-
namic process controlled by the ANS which allows throttling or stimu-
lation in effector tissue including microcirculation and immune cells 
(Jänig, 2011; Jänig, 2014a; Kenney and Ganta, 2014). 
During an immune response (e. g. in a viral infection) the brain and 
the immune system “talk to each other” (Elenkov et al., 2000; Tracey, 
2002; O’Connor et al., 2004; Jänig, 2014a; Ji et al., 2016) via afferent 
and efferent pathways and know about their mutual state (Figs. 2 and 3). 
Immune cells express adrenoceptors (Bellinger and Lorton, 2014), and, 
conversely, nerve endings of sensory neurons register changes in the 
local concentration of immune mediators (cytokines, chemokines) and 
transmit this information to the brain (Tracey, 2002; Schaible, 2014). 
Autonomous centers in the brain localize the tissue damage at a specific 
location in the organism, which would not be possible via the blood-
stream. Inflammatory mediators such as cytokines including chemo-
kines are actually neuromodulators (Schaible et al., 2011; Chiu et al., 
2013; Ji et al., 2016). In this localized neuroinflammation, also glial cells 
in the dorsal root ganglia (DRG), the spinal cord and the brain are 
Fig. 1. Overview of affected systems, e. g. following a virus infection like 
Covid-19. 
The grey area symbolizes that the autonomic nervous system (ANS) is inte-
grated in the communication of all systems and has a coordinating function. 
The black arrows symbolize that the systems are connected to each other via 
neuronal and non-neuronal feedback loops and are therefore interdependent. 
The same neuronal and non-neuronal substances can have both activating and 
inhibiting effects, depending on the current state of the system as well as on the 
point in time. (For literature, see text). Interestingly, the reactions in this system 
take place in principle in the same way, regardless of whether the initial 
stimulus was a viral infection, mechanical trauma, psychological stress, or other 
cause. The clinical picture – the disease – is then determined by the organ or 
organ system mainly affected (see text). In our opinion, the consequences of 
acute hyperinflammation such as ARDS, endothelial dysfunction, microcircu-
lation disturbance, and coagulopathy are not different entities in a viral 
infection, but an expression of a malfunction of the ANS with sympathetic 
hyperactivity. 
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activated. 
Interestingly, not only immune cells (macrophages, monocytes, 
lymphocytes) can produce cytokines, but also neurons of the central and 
peripheral nervous system, microglia and astrocytes, and vascular 
endothelial cells (Galic et al., 2012). Peripheral nerves have partly the 
same molecular recognition pathways (such as toll-like receptors) as the 
immune cells (Chiu et al., 2012; Chiu et al., 2013), allowing a very direct 
and fast communication (interaction). During noxious stimulation 
(trauma, toxins, viruses, bacteria, etc.) nerve fibers themselves release 
proinflammatory neuropeptides such as substance P (SP) and calcitonin 
gene-related peptides (CGRP). These are also released by immune cells 
such as macrophages, lymphocytes and mast cells (Stanisz et al., 1986). 
This results in neurogenic inflammation with plasma extravasation and 
edema (Chiu et al., 2012; Chiu et al., 2013; Jänig, 2014a; Ji et al., 2016; 
Matsuda et al., 2019). Neuropeptides secreted by nerve fibers can in turn 
induce cytokine production in immune cells (Ansel et al., 1993; Hosoi 
et al., 1993; Stanisz, 2001; Veres et al., 2007) and generate in this way a 
positive feedback loop. Neurogenic inflammation also occurs in virus- 
associated respiratory infections (King et al., 2001), and viral in-
fections can also activate toll-like receptors in nociceptors thus allowing 
a modulation of pain and local neuroinflammation (Ji et al., 2016). 
3. Why a stellate ganglion block (SGB)? 
Surprisingly, the basic neuroimmune interactions in heterogenous 
clinical pictures (“diagnosis”) with overreaction of the immune and 
Fig. 2. Autonomic nervous system and immune system: central and peripheral 
communication (more details in Fig. 3). 
Positive feedback loops exist between AND within the central and peripheral 
communication. Example: Elements of peripheral communication sensitize each 
other: Thus, immune cells AND nerve fibers produce cytokines and substance P 
(SP), which in turn induce the immune cells and nerve fibers to produce even 
more cytokines and SP (positive feedback loop). The brain is then informed of 
the cytokine and SP concentration; it knows via the afferent nerve fibers the site 
of tissue damage and the incipient inflammation. Now, this information is 
processed (central communication) and the resulting output is then communi-
cated to the periphery by means of the efferents shown here (communication 
between center and periphery). 
Fig. 3. Schematic and simplified overview of the autonomic nervous system 
and immune system and influence of the stellate ganglion block (direct and 
indirect) on several systems simultaneously (blue fields; see Section 3). 
Representation of different levels of the “crosstalk” between nervous system 
and immune system (described step by step in the text). Each “part” is depen-
dent on the whole system, and the function of the “parts” can hardly be 
considered in isolation. In addition to negative feedback loops, several positive 
feedback loops (iterations) are formed so that the system gets a high 
complexity. 
The “reset” by means of stellate ganglion block not only affects the fibers of the 
autonomic nervous system, but also the subsequent reactions triggered by it, 
such as the regulation of the immune and inflammatory system and thus, 
cytokine production, too (see Table 1). 
CP: Celiac plexus; HPA: hypothalamic-pituitary-adrenal; RVLM: rostral 
ventrolateral medulla; SGB: stellate ganglion block. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web 
version of this article.) 
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inflammatory system do not seem to differ (see Section 3.5), and thereby 
allow principally to be influenced (peripherally and centrally) by SGB 
(Fig. 4) (see Section 3.5). In the past, we have gained experience with 
SGB in heterogeneous clinical pictures which were accompanied by in-
flammations, immune disorders, circulatory disorders, and pain (Barop, 
2017; Fischer, 2020). Therefore we thought of a common pathogenetic 
mechanism and a “cooperation” between the ANS and the immune 
system in inflammations, and that their central mechanisms are also 
influenced by SGB. 
3.1. Anatomy and physiology of the stellate ganglion 
The sympathetic SG is located at the level of the 1st rib head in the 
lamina praevertebralis fasciae cervicalis. The neurons of the ganglion 
receive their impulses via the rami communicantes albi from the spinal 
core areas of the nucleus intermediolateralis from C8 to Th5. After 
switching via divergence principle (McLachlan, 2003) to postganglionic 
neurons in the SG, the latter supply the upper body quadrant. 
The SG modulates the functions in its immediate area of supply: 
brain, neck, lung, heart, upper extremity, vessels including microcircu-
lation and endothelial function, interstitium, and immune system. The 
SG does not only influence the immune processing in the periphery but 
also brain areas involved in the control of the immune system. There-
fore, the influence of the SG is not limited to pathophysiological pro-
cesses in its immediate peripheral supply area (e. g. viral pneumonia, 
myocarditis) of the upper body quadrant, but also modifies inflamma-
tion remote from the SG, e. g. of the intestine. The reason for this is that 
neuronal and non-neuronal (cytokines, etc.) afferent signals from the 
intestine are received and integrated in the vagal and sympathetic brain 
centers which in turn influence the intestine (and its immune system) by 
feedback (Fig. 3). The autonomous centers in the brain are also under 
the influence of the SG (Westerhaus and Loewy, 2001), explaining why 
the brain (supplied by the SG) can provide ubiquitous immune responses 
and influence inflammation via the sympathetic and parasympathetic 
system (Elenkov et al., 2000; Tracey, 2002; Tracey, 2009; Jänig, 2014b; 
Lipov and Candido, 2017). In a review of the literature of the anatomy of 
SG we noted that the sympathetic and vagal fibers are intertwined by a 
continuous commingling and via rami communicantes (Puente de la 
Vega Costa et al., 2016). Therefore, SGB is not a purely sympathetic 
block; vagal fibers are always influenced by the injection, partly because 
of their anatomical proximity, partly through the rami communicantes. 
This is desirable because both sympathetic and vagal efferents and af-
ferents are important for the temporary interruption of the immune and 
inflammatory reflex paths (Puente de la Vega Costa et al., 2016). 
3.2. Regulation of the acute neurogenic hyperinflammation (cytokine 
storm) by SGB 
In the literature, the terms “proinflammatory”, “hyperinflammation” 
and “cytokine storm” are not exactly defined. We use the terms analo-
gous to the following descriptions. 
Proinflammatory: by this we mean substances or processes that have 
a proinflammatory effect, such as substance P, proinflammatory cyto-
kines, etc. Here, the proinflammatory effect may well be physiological 
for defense against infectious agents, in trauma, etc. (Esch and Stefano, 
2002). 
Hyperinflammation: this goes beyond the physiological inflamma-
tory response and causes tissue damage. Scientific publications and the 
media often use the terms “hyperinflammation” and “cytokine storm” 
analogously, especially in connection with Covid-19. This is practicable 
but not very precise. We think the term “acute hyperinflammation” is 
more precise. 
Cytokine storm has no precise definition (Sinha et al., 2020) and “no 
single definition of cytokine storm as an umbrella term is widely 
accepted” (Fajgenbaum and June, 2020). Cytokine storm is a hyperac-
tive immune response with excessive increased cytokines and other 
mediators. This is more than a physiological innate immune answer of 
an infection; cytokine storm causes via hyperinflammation cell and 
organ damage and often death (Burke et al., 2020; Sinha et al., 2020; 
Kim et al., 2021). 
In the following, we postulate that in many tissue damages, e. g. after 
virus infection, the overreaction of the immune system (e. g. cytokine 
storm) with hyperinflammation is the consequence of an SNS over-
reaction, and that SGB is a logical possibility to counteract it (Figs. 2 and 
3). The physiological balance between the SNS and the vagus nerve is 
biased towards SNS dominance (Alston et al., 2011; Puente de la Vega 
Costa et al., 2016; Koopman et al., 2017). Speranski, a student of Pavlov, 
was able to show in 1950 in animal experiments that after experimental 
preload of the SNS (“first strike”) (e. g. chronic artificial hypothalamus 
and pituitary gland irritation), a subsequent, additional stimulus (“sec-
ond strike”) caused various overshooting, sympathetically triggered, 
reflectoric inflammations (such as arthritis). For Speranski (1950), 
excessive inflammation was the result of an overreaction of the pre-
loaded SNS. 
The imbalance in the ANS can also promote inflammation when the 
SNS is dominant (Alston et al., 2011; Puente de la Vega Costa et al., 
2016; Koopman et al., 2017). Generally (with exceptions), the hyper-
activated SNS has a proinflammatory effect (Schaible and Straub, 2014) 
while the activated parasympathetic fibers of the vagus nerve have an 
anti-inflammatory effect. Nevertheless, the sympathetic and para-
sympathetic nervous systems cannot be considered in isolation; they are 
more than the sum of their parts (Fischer, 1998; Tracey, 2002), since 
they are not only centrally but also peripherally more closely inter-
twined than previously assumed (Puente de la Vega Costa et al., 2016) 
(see above). Although the pathophysiology was not known in detail at 
the time of Speranski’s experiments, later research has confirmed the 
“leadership” of the ANS, especially of the SNS, in (excessive) immune 
reactions and inflammation (Piedimonte et al., 1999; King et al., 2001). 
Tracey, one of the pioneers of seeing inflammation and immune pro-
cesses as part of a neuronal reflex involving the SNS and the vagus 
(Tracey, 2002; Tracey, 2009), proposed neuronal different “setpoints” 
for the immune response to a stimulus such as infection: A normal 
“setpoint” results in a protective response (normal inflammation and 
tissue repair), a decreased “setpoint” in immunosuppression with 
Fig. 4. The stellate ganglion block (SGB) simultaneously regulates the systems 
linked to the autonomic nervous system (ANS). 
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increased infection, and an increased “setpoint” in hyperinflammation 
and tissue damage. Similar as in Speranski’s (1950) experiments, a 
direct (hypertension [Kumagai et al., 2012], obesity, or stress) or indi-
rect (organ damages) preload on the SNS may shift Tracey’s “setpoint” 
towards an increase (corresponding to Speranski’s “first strike”), so that 
the additional stimulus – such as an infection (Speranski’s “second 
strike”) – leads to an overreaction of the SNS which disturbes the bal-
ance in the ANS (Speranski, 1950; Fischer, 2002; Tracey, 2009; Barop, 
2017; Fischer, 2019). This hyperactivity would then be measurable by a 
cytokine storm and other laboratory parameters as well as tissue dam-
age. In such situations, various authors have proposed to stimulate the 
vagus nerve in order to improve the balance between the sympathetic 
system and the vagus nerve (Tracey, 2002; Tracey, 2009; Pavlov and 
Tracey, 2015; Breit et al., 2018; Pavlov et al., 2020; Tsaava et al., 2020; 
Caravaca et al., 2019). Effects of vagus nerve stimulation (reduction of 
inflammation, decreased cytokine production) correspond in principle 
to SGB which we are promoting here (see Section 5.3). Even though the 
Tracey model focuses predominantly on systemic autoimmune diseases 
and not on viral infections, there is striking evidence that the pathoge-
netic reflex mechanisms might be the same (uniform pathogenesis) with 
different initial (also viral) stimuli (see Section 3.5.2). 
The severity of inflammatory disease is also closely related to the 
activity of sensory TRPV1-expressing neurons (transient receptor po-
tential channel, formerly known as vanilloid receptor 1 or capsaicin 
receptor) in the truncus sympathicus and in the vagus nerve, as well as to 
the activity of sympathetic and vagal efferents in the lungs which 
modulate inflammation and immune system (Baral et al., 2018; Nahama 
et al., 2020). These neurons are in cross talk with the immune system 
(Tränkner et al., 2014; Chavan et al., 2017) and can release more 
proinflammatory molecules such as SP and cytokines once activated. In 
order to reduce overproduction of cytokines, the authors suggest to 
block TRPV1-positive fibers which produce SP. Nahama et al. (2020) 
propose a periganglionic block corresponding to SGB. Baral et al. (2018) 
confirmed this approach in animal studies (ablation of TRPV1). 
Numerous authors stress the importance of the nervous system in 
excessive inflammation: Neuronal reflex pathways can increase the 
secretion of proinflammatory cytokines and inflammation (Heijnen 
et al., 2002; Tracey, 2002; Perez et al., 2009; Jänig and Baron, 2011; 
Bellinger and Lorton, 2014). A virus-induced exaggerated immune 
response (cytokine storm) is considered a consequence of excessive 
neurogenic mechanisms (prolonged airway hyperresponsiveness) (Per-
ianin et al., 1989; Mejías et al., 2005). Cytokine overproduction seems to 
be important in tissue damage, e. g. in the lung (Wang et al., 2020). In 
order to regulate the cytokine storm, we believe it is crucial to regulate 
the overshooting neurogenic mechanisms, e. g. by SGB, to achieve a 
different “setpoint” (Tracey, 2009). 
Ligand (virus)-receptor interactions, too, activate the secretion of 
proinflammatory cytokines. The latter activate sensory nerve fibers 
(Fig. 2) and evoke a reflex response via the SNS and vagus (Tracey, 
2009). If this response is overshooting and sympathetic-dominant, 
electrical vagus nerve stimulation can be applied therapeutically 
(Tracey, 2002; Tracey, 2009), which corresponds functionally to SGB in 
the case of a shift towards sympathetic nerve activity. SGB reduces the 
production of TNF-α, IL-1, IL6, and IL-8 (Liu et al., 2013; Yang et al., 
2015; Chen et al., 2018) and increases the production of IL-10, which is 
anti-inflammatory (Table 1) (Liu et al., 2013; Yang et al., 2015; Chen 
et al., 2018). Chemical sympathectomy showed basically the same re-
sults (Grebe et al., 2010). Stimulation of the vagus nerve also reduces the 
production of proinflammatory cytokines in the spleen by unknown 
mechanisms (Tracey, 2009), stressing the communication (interaction) 
between the nervous and the immune system (see above). If even the 
nucleus tractus solitarius is affected by virus invasion, as described. e. g. 
in some cases of Covid-19 (Li et al., 2020), it can lead to a sympathetic 
(catecholamine) storm, which then induces a cytokine storm leading to 
neurogenic pneumonia (Ur and Verma, 2020a; Ur and Verma, 2020b). 
Early treatment of the nervous system is – as the authors stress – crucial 
in this situation (Ur and Verma, 2020b). We believe that SGB is the right 
choice because it reduces hyperinflammatory mechanisms in the CNS as 
well as in lung and heart area etc. 
As we could show in our previous works, the spinal cord is also 
strongly involved in the development of peripheral inflammation, with 
indications that the effects are mediated via the SNS (Boettger et al., 
2010a, 2010b). SGB – as early as possible (Strong et al., 2018) – is a 
logical intervention to interrupt feedback loops. 
We assume that a neuroplastically altered SG intensifies pneumonia 
towards ARDS, consistent with the neural hypothesis of lung edema (Ur 
and Verma, 2020b). Neuroimmunologically controlled hyper-
inflammation also involves functional and structural changes in the 
endothelium and microcirculation and possibly also coagulopathy (see 
Sections 3.3 and 3.4). This results in further feedback loops (Fig. 1). 
Since SGB shuts down the mentioned feedback loops simultaneously 
(because they are interdependent), the neuroimmune system has now 
the chance to reorganize itself (autoregulation). This reorganization is 
therefore not tied to the duration of action of the LA (procaine); rather, it 
far outlasts the short-term SGB (Puente de la Vega Costa et al., 2016; 
Barop, 2017; Fischer, 2019). 
3.3. Regulation of the endothelial dysfunction by SGB 
The ANS influences endothelial functions from outside the vessels 
(Amiya et al., 2014). Blood vessels are innervated by sympathetic and – 
only in a few places in the body – parasympathetic nerve fibers. Endo-
thelial dysfunction and inflammation are the consequence of patholog-
ically increased sympathetic nerve activity (Sheng and Zhu, 2018). On 
the other hand, the endothelium can influence the SNS via vasoactive 
factors. This results in complex interactions involving positive feedback 
loops. Inflammation impairs the endothelial function (Sinisalo et al., 
2000). Even anxiety or sympathetic hyperactivity, e. g. with Takotsubo 
syndrome (Naegele et al., 2016) is associated with endothelial 
dysfunction (Narita et al., 2007) further stressing the connection be-
tween ANS, immune system, and endothelium (Mousa et al., 2010). 
Endothelial cells can also produce vasoactive substances such as ni-
tric oxide (NO) and endothelin. Endothelin maintains local and gener-
alized processes. It can stimulate the peripheral and central SNS and can 
also be released by postganglionic sympathetic neurons and control 
catecholamine release and vascular tone (Yamaguchi, 1997; Schiffrin, 
2012). In cooperation with the SNS, endothelin has a pathophysiological 
role in arterial hypertension including pulmonary hypertension, 
atherosclerosis, vascular inflammation with fibrosis, and pulmonary 
fibrosis (Schiffrin, 2012). Increased sympathetic tone combined with 
infiltration of the blood vessel wall can lead to hypertension (Zhang 
et al., 2020). Chen et al. (2012) observed a decrease in endothelin (and 
hypertension) in rats after applying SGB. Like endothelin, NO is involved 
in the complex regulatory circuits of endothelium–inflammation–ANS 
Table 1 
Effects of the stellate ganglion block.  
Regulation of the immune system/hyperinflammation   
• Reduction of natural killer cell activity (Sugimoto et al., 1999; Yokoyama et al., 
2000)  
• Reduction of inflammatory cytokines IL-1, IL-4, IL-6, IL-8, TNF-α (Liu et al., 2013; 
Yang et al., 2015; Chen et al., 2018)  
• Increase of antiinflammatory cytokine IL-10 and of CGRP (Liu et al., 2013; Yang 
et al., 2015; Chen et al., 2018) 
Regulation of the endothelial dysfunction (Chen et al., 2012) 
Regulation of microcirculation and coagulopathy (Levy and Lorch, 1996; Hanamatsu 
et al., 2002; Pfister and Fischer, 2009; Yamazaki et al., 2012; Zhou et al., 2014;  
Punj, 2019) 
Reduction of (neurogenic) pulmonary edema (Pierach and Stotz, 1952; Zhang et al., 
2013; Liu et al., 2017; Chen et al., 2018) 
Reduction of pulmonary arterial hypertension (Myers et al., 1998) 
Reduction of pathological positive feedback loops (Fischer, 2003; Jänig, 2011;  
Fischer, 2019)  
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and has been favorably influenced by SGB in animal experiments (Chen 
et al., 2012). Leptin, released from adipocytes, also plays a role in 
arterial hypertension in collaboration with the SNS, and it causes 
endothelial dysfunction and increased blood pressure (Wang et al., 
2013). Both pathologies are mediated by SNS activation (Wang et al., 
2013). These effects of leptin were neutralized by sympathetic dener-
vation (ganglionectomy) (Wang et al., 2013). That obesity and hyper-
tension are risk factors for severe courses of Covid-19 is also 
understandable from this point of view (see also Section 5.2). 
3.4. Regulation of microcirculation – disturbance and coagulopathy by 
SGB 
The severity of an infectious disease is not only determined by patho-
genic damage and reflectory (hyper-)inflammation of the organs (e. g. in 
pneumonia), but also by microcirculatory disturbance with hyper-
coagulopathy, as with Covid-19. Inflammation is the predominantly sym-
pathetically controlled vascular response to irritants such as viruses and 
others (Ricker, 1924; Marvar and Harrison, 2012). The response includes 
vasodilation with disturbed blood flow in irritated tissue, increased 
vascular permeability, production of cytokines and chemokines, and 
mobilization of immune cells. In a feedback loop, the brain modulates the 
intensity of inflammation after being informed by sensory nerve fibers from 
the irritated tissue (Figs. 2 and 3) (Sternberg, 2006; Marvar and Harrison, 
2012). In 1994 already, Greiff et al. reported a microvascular exudative 
hyperresponsiveness in human coronavirus-induced common cold. Salgado 
et al. (2010) described disturbed microcirculatory blood flow in patients 
with severe influenza A (H1N1). The importance (and the link) of micro-
vascular alterations and coagulopathy with microthrombi are also dis-
cussed in the pathogenesis of Covid-19 (Damiani et al., 2020; Magro et al., 
2020; Varga et al., 2020; Spiezia et al., 2020). In our opinion, the SNS 
should be more considered. Overactivity of the SNS including the 
hypothalamic-pituitary-adrenal axis can lead to hypercoagulability with 
thrombus formation (von Känel and Dimsdale, 2000; Pagano et al., 2014). 
Microthrombi of the lungs and other organs are mainly mediated by cy-
tokines (Levi et al., 2008; Merad and Martin, 2020), and therefore can be 
triggered by a pathologic ANS hyperactivity. Wang et al. (2019) also 
described the role of sympathetic activity on the pathogenesis of pulmo-
nary embolism. Crucial is sympathetic hyperactivity which influences 
coagulation and fibrinolysis pathways and causes microthrombi with 
increased plasma D-dimers (Ur and Verma, 2020b). SGB also has an effect 
on pulmonary arterial hypertension and thus on microcirculation (Myers 
et al., 1998; Zhao et al., 2019) and is therefore a logical intervention for 
microcirculation disorders and coagulopathy (Murakawa, 1993; Levy and 
Lorch, 1996; Hanamatsu et al., 2002; Pfister and Fischer, 2009; Yamazaki 
et al., 2012; Zhou et al., 2014; Punj, 2019) (Fig. 4). 
3.5. Further clinical and experimental data 
3.5.1. SGB in pneumonias 
The SNS increases proinflammatory cytokines and exacerbates 
influenza A virus pathogenesis (Grebe et al., 2010). The authors showed 
that peripheral chemical sympathectomy in mice reduced morbidity and 
mortality from influenza A virus-induced pneumonia. After sympa-
thectomy they observed a reduced cytokine response and a reduced 
inflammatory influx of monocytes, neutrophils, and natural killer (NK) 
cells. In the old works by the surgeon Leriche, it is suggested that sym-
pathectomy for inflammation corresponds in effect to repeated SGB with 
procaine (Leriche and Fontaine, 1934). 
The theoretical background of hyperinflammation due to disequi-
librium of the ANS with a dominance of the sympathetic part in acute 
lung injury stimulated the animal experiments of Liu et al. (2017). They 
showed that the regulation of the ANS, especially the sympathetic part, 
by SGB reduced inflammation and improved lung function in rabbits. In 
principle, vagus nerve stimulation produces a better balance in the ANS 
in case of overstimulated SNS. Vagus nerve stimulation also had an anti- 
inflammatory effect, as did the administration of cholinesterase in-
hibitors, but both were less potent than SGB (Liu et al., 2017). SGB not 
only reduced proinflammatory cytokines, but also the swelling of 
microvascular endothelial cells and epithelial type I cells in the lung (Liu 
et al., 2017). 
Chen et al. (2018) showed in septic rats with acute lung injury that 
SGB reduces TNF-α and IL-6, increases the anti-inflammatory IL-10, and 
inhibits the infiltration of inflammatory cells into lung tissue. 
Baral et al. (2018) produced a methicillin-resistant staphylococcus 
aureus-pneumonia in mice: TRPV1-expressing sensory neurons in the 
truncus sympathicus and the vagus nerve were chemically ablated (this 
corresponds in our opinion to the repeated SGBs in this circuit). Survival 
was improved and cytokine storm significantly reduced. Thus reduced 
activity of TRPV1-positive nerve fibers therefore probably prevents the 
transition of mild pneumonia into ARDS. In our opinion, this is a further 
plausible reason for SGB in such situations, supported by the fact that the 
TRPV1 channels can be influenced by LA such as procaine (Yanagidate 
and Strichartz, 2007). This even raises the question of the additional 
benefit of an intravenous procaine infusion (Papathanasiou, 2020), 
especially since procaine is anti-infectious, anti-inflammatory and 
antithrombotic (Cassuto et al., 2006; Konrad et al., 2006). 
Okada et al. (1996) found a reduction in the activity of NK-cells in 
the spleen after resection of the cervical border strand, and Sugimoto 
et al. (1999) found that SGB causes a short-term reduction in cytotoxic 
T-cell activation, i. e. in NK-cells. Yokoyama et al. (2000), also found a 
modified distribution of lymphocyte subsets and NK cell activity 
following SGB. SGB also regulates the increased hormone release of the 
HPA axis, especially the norepinephrine levels (Yokoyama et al., 2000). 
3.5.2. SGB in other situations of inflammation or acute hyperinflammation 
(cytokine storm) 
The following studies and experiments come to uniform basic 
statements about the effect of SGB – although different organ systems 
such as the lungs, vessels, etc. or a trauma, a postoperative state, an 
autoimmune disease are affected. In principle, the mechanisms of pre-
dominantly sympathetic-triggered inflammation or hyperinflammation 
are always the same since the body has just a few reaction patterns to 
respond to stimuli such as infection, trauma, etc. The neuro-
immunological and inflammatory cascade seem to be in motion 
regardless of the initial stimulus. The affected end organ determines the 
specific clinical appearance. Some examples: Analogous to the over-
reaction (cytokine storm) of the neuro-endocrine-immune network in 
Covid-19, the same processes are found in the early phase of severe 
trauma. It is called systemic inflammatory response syndrome (SIRS) 
(Liu et al., 2013) and is one of the major factors in complications, organ 
failure and death. SIRS, too, is associated with an overproduction of 
proinflammatory cytokines such as IL-1β, IL-6 and TNF-α. SGB regulates 
the early systemic inflammatory response in severe trauma patients (Liu 
et al., 2013). The authors found that the concentrations of IL-β, IL-6 and 
TNF-α (but not IL-4 and IL-10) are significantly lower after SGB than in 
the control group without SGB. SGB regulates the hyperactive neuro-
endocrine-immune response to allow homeostasis and is recommended 
as an effective therapy for impending SIRS. 
Yang et al. (2015) found that SGB can regulate cellular and humoral 
immune functions in patients with traumatic brain injury (TBI); like-
wise, it can improve an overreacting nerve-endocrine-immune system, 
excessive vasoconstriction, abnormal blood rheology, and thus restore 
the balance between the sympathetic (excessive sympathetic tone) and 
parasympathetic nervous systems. In 50 patients with TBI, Yang et al. 
(2015) showed that the excessive inflammatory response after TBI is an 
important reason that aggravates the secondary brain injury. IL-1β, IL-6 
and TNF-α were significantly reduced after SGB compared to the control 
group. The authors also suspect a positive effect of SGB on central and 
peripheral vasoconstriction. 
Thus, severe trauma can cause an overreactive stress response 
involving the complex feedback in the neuro-endocrine-immune system 
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(Molina, 2005; Liu et al., 2013; Yang et al., 2015). Normally, an 
adequate stress response is protective. The SNS plays the most important 
role in these interactions but the balance with the parasympathetic 
nervous system is important (Puente de la Vega Costa et al., 2016). So, 
even in severe trauma, one of the most urgent goals is to prevent e. g. a 
cytokine storm, just as with Covid-19. Thus, the question also arises 
whether the term SIRS should be defined as a general principle (uniform 
pathogenesis with different initial stimuli, i. e. causes) in different dis-
eases with pathological hyperinflammation (as with Covid-19). Notably, 
the principal – physiological or overshooting and therefore damaging – 
reactive neuroimmunological mechanisms with physiological or 
hyperinflammation are the same, regardless of whether their trigger is 
trauma, toxins, viruses, bacteria, etc. or psychological stress. 
There are further examples: In a prospective, double blinded ran-
domized parallel study SGB applied before laparoscopic gynecologic 
surgery decreased pain significantly immediately after surgery 
(Rahimzadeh et al., 2020). Postoperative pain always has an inflam-
matory component. Another randomized, double blind, placebo- 
controlled study (Kumar et al., 2014) showed that SGB had a signifi-
cant analgesic effect on orthopedic upper limb surgery, additionally 
measured by opioid consumption. García-Morán et al. (2013) and Guo 
et al. (2014) demonstrated a favorable effect on perioperative stress- 
related cytokine production. Sympathetic hyperactivity is regulated 
not only peripherally, but also centrally via the hypothalamus (Amino 
et al., 2007; Taneyama and Goto, 2009), and therefore SGB also 
improved chronic inflammatory bowel disease (ulcerative colitis), as 
shown as an additional intervention with sulfasalazine medication. In 
addition to a better clinical course, a reduction in inflammatory medi-
ators (IL-8), faster mucosal regeneration, less pain and fewer compli-
cations were observed (Zhao et al., 2017). The inflammatory response 
and mortality of mice with combined radiation and burn injury can be 
decreased by SGB (Lu et al., 2006). SGB can prevent or reduce the 
development of neurogenic edema in the lungs (Zhang et al., 2013) and 
possibly in the brain (Fischer, 1995). An anti-inflammatory effect of SGB 
in pulmonary edema is also suggested by Pierach and Stotz (1952), Liu 
et al. (2017), Chen et al. (2018), Ur and Verma (2020a, 2020b). Acti-
vation of sympathetic fibers with nuclei in the upper thoracic spinal cord 
can cause pneumonitis (Lee, 2009; Lee and Yu, 2014), speaking for their 
regulation (temporary deactivation of the nerve fibers) by SGB. How-
ever, the success depends on the time of inflammation at which the 
intervention is carried out. It seems most successful in the early stages, 
as we could show (Schaible and Straub, 2014; Strong et al., 2018). Other 
studies have also shown a time-dependent effect of SGB (Rahimzadeh 
et al., 2020). 
On the question of the timing of the SGB: Much is still unknown. One 
of the explanations may be that similar to the pain memory, an 
inflammation memory may develop under the described positive feed-
back loops. In other words, sensitization processes lead to neuroplastic 
changes over time. These may be reversible in some cases, but the timing 
of the intervention is logically important – we also see the best results 
clinically when we intervene early with repeated SGB in the sense of 
“desensitization” (typical for e. g. CRPS [Pfister and Fischer, 2009]). In 
CRPS for example, central neuroplastic changes also result over time, 
which are even visible on imaging in the cortex (Maihöfner et al., 2003). 
It is logical that in the late stage a SGB has less effect. We can try to argue 
analogously for the neuroimmune system. However, we are only at the 
beginning of a new idea with the mechanisms of action. 
In Covid-19 analysis of cytokine levels (“inflammatory phenotyp-
ing”) can identify patients at risk of deterioration (Burke et al., 2020; 
Caricchio et al., 2021). This can – together with the clinical presentation 
– help to find the right timing for SGB. 
3.6. Regulation of acute hyperinflammation (cytokine storm) without 
deterioration of immunity or increase in viral load by short-term SGB 
In cases of imminent or manifest cytokine storm e. g. in Covid-19, we 
rather suggest regulation of the neuroimmune system by short-lasting 
SGB than blockade of immune functions by selective drugs, since a 
“selective” drug-induced blockage of parts of the neuroimmunological 
processes may be associated with serious side effects including deteri-
oration of immunity and subsequent secondary infection or increase in 
viral load (Sanders et al., 2020; Velavan and Meyer, 2020). The 
administration of corticosteroids is also controversially discussed (Das 
et al., 2020). They should not be administered routinely in cases of 
cytokine storm, but only when severe edema and hyaline membranes 
occur (Xu et al., 2020). This is easy to understand from pathophysiology: 
mediated by the HPA axis, the serum cortisol concentration is already 
elevated under disease stress. An “artificial” increase in cortisol con-
centration results in a significant increase in mortality from Covid-19 
(Tan et al., 2020). 
Since (despite the term SGB) we do not block but regulate, we do not 
interfere with the body’s natural ability to develop an immunological 
memory (adaptive immune system) and therefore there is no greater risk 
of subsequent re-exposure. It is true that the SGB modifies the distri-
bution of the lymphocyte subsets and the NK cell activity (increase in the 
proportion of B- and T-cells, and a decrease in NK-cells) (see Section 
3.5.1), but these effects were transient (Yokoyama et al., 2000). The 
transient SGB serves mainly to regulate an excessive immune response to 
a physiological immune response. 
3.7. Properties of procaine 
In contrast to amide-structured LA (lidocaine, bupivacaine), pro-
caine has a direct vasodilating (regulating) effect in addition to the 
sympatholytic effect. Furthermore, procaine has an antiinflammatory 
effect (Hollmann and Durieux, 2000; Cassuto et al., 2006). LA also act on 
non-neuronal cells such as mast cells, neutrophils and monocytes as well 
as on cytokine production and also have antibacterial and antiviral ef-
fects (Hollmann et al., 2001; Cassuto et al., 2006). LA can also modulate 
an excessive inflammatory response that is no longer protecting, but 
destroying tissue (Brown et al., 1995; Groeben et al., 1996; Groeben 
et al., 1999; Hollmann and Durieux, 2000). In addition, LA can reduce 
inflammation in the microglia (Zheng et al., 2019). 
Procaine has no significant side effects (Fischer et al., 2005; Fischer 
et al., 2010; Barop, 2017) and no interactions with other drugs because 
it is not broken down by the liver but by pseudocholinesterase, which is 
ubiquitously present. This is also an advantage in Covid-19, since most 
of the time, severely ill patients are elderly, receiving poly-
pharmaceutical treatment. 
4. Applying SGB using a minimally invasive technique 
In 2016 we presented a modified technique (Puente de la Vega Costa 
et al., 2016) based on Leriche and Fontaine (1934), Dosch (1986), 
Fischer (1998), and Barop (2017). Technical details were described in 
“Autonomic Neuroscience” (Puente de la Vega Costa et al., 2016). We 
recommend the bilateral SGB with a time interval of ca 1 h (disappearing 
Horner complex) twice daily for 2 or 3 days. 
4.1. Material 
Procaine 1% 5 ml each side without any additives. Needle: 20 × 0.4 mm 
or 12 × 0.3 mm, depending on body type (short needles are possible 
because of the remaining finger on Chassaignacs tubercle). 
This technique allows a very shallow depth of the injection, so that 
very thin needles can be used, which allows the stellate injection even in 
anticoagulated patients. However, with extremely thin needles, aspira-
tion is more difficult and must be performed slowly and continuously. 
For safety reasons, anticoagulated patients must be given several mi-
nutes of compression at the injection site. 
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4.2. Possible complications 
Paresis of the recurrent or phrenic nerve on the opposite side can 
lead to breathing problems. Accidental injection of a LA into a brain- 
bound blood vessel or into the cranial area of the cerebrospinal fluid 
space (cave: cervical cerebrospinal fluid cyst) can cause cramps, un-
consciousness, cardiac and respiratory arrest. 
5. Discussion 
5.1. The neuroimmune system – complex and nonlinear? 
There is evidence that an imbalance in the ANS (in particular an 
excessive sympathetic tone) due to pre-existing conditions is at the 
beginning of the overshooting reactions in Covid-19 and other diseases. 
Even small changes in non-physiologically balanced complex systems 
can therefore have a major effect. This is typical in a system with 
interdepending positive feedback loops (iterations) as described in the 
previous chapters. This gives the neuroimmune system a complex 
nonlinear character, analogous the mathematical chaos theory as it was 
described for nature and biology (Mandelbrot, 1967; Lorenz, 1972; 
Nicolis and Prigogine, 1977; Feigenbaum, 1978; Kluge and Neugebauer, 
1994). We postulate several positive feedback loops dependent on the 
ANS which play a role in the overreaction of the neuroimmune system, 
in which neural and humoral factors reinforce each other. In positive 
feedback loops it is often difficult to find the “starting points”. We will 
try to illustrate this with some examples: Since neurons express re-
ceptors for inflammatory mediators (Schaible, 2014; Ji et al., 2016), SP 
or cytokines activate sensory nerve fibers to increase the synthesis 
(White et al., 2005; Zelenka et al., 2005; Xu et al., 2018) and release of 
even more SP (O’Connor et al., 2004; Matsuda et al., 2019) and cyto-
kines (Galic et al., 2012). This positive feedback loop is a very fast way to 
reach high concentrations of SP and cytokines, but there is also the 
danger of overreaction when the system is already preloaded. This could 
be one of the mechanisms of a cytokine storm. SP can additionally 
stimulate the production of cytokines by macrophages (e. g. IL-1, IL-6 
and TNF-α) (Bill et al., 1979) and induce chemotaxis and degranulation 
of human neutrophils (Serra et al., 1988; O’Connor et al., 2004). 
Furthermore, immune cells express adrenoceptors (Bellinger and Lorton, 
2014), induced by proinflammatory cytokines (Heijnen et al., 2002; 
Perez et al., 2009). Thus, the SNS can induce their cytokine production – 
and cytokines are also produced by nerve fibers themselves (White et al., 
2005; Zelenka et al., 2005). Furthermore, certain cytokines (IL-1) in-
crease the synthesis of SP in sympathetic ganglia (Freidin and Kessler, 
1991) and stimulate their secretion in afferent neurons (Inoue et al., 
1999). The production and secretion of SP by lymphocytes and macro-
phages (De Giorgio et al., 1998; Lai et al., 1998) causes further positive 
feedback with expansion and intensification of neurogenic inflamma-
tion. Positive feedback loops are strongly interconnected, typical for a 
complex, iterative, chaotic system. 
The question arises if positive feedback loops make sense in physi-
ology. In our opinion these iterations are the quickest way to generate a 
physiological inflammation. In case of an infection, cytokines and SP can 
be provided very quickly. However, there is also the disadvantage that 
such systems are unstable, and we hypothesize that if the SNS is pre-
loaded (such as hypertension, obesity, stress, negative emotions) or the 
regulatory capacity reduced, the (positive feedback) system can over-
react and lead to a cytokine storm with a consecutive acute hyper-
inflammation in case of viral infections such as SARS-CoV-2. Thus, we 
believe, that the severity of e. g. viral pneumonia or even ARDS does not 
depend linearly on the initial stimulus (amount of virus). Depending on 
time and the current state of the system, the same parts of the ANS can 
have either an activating or inhibiting effect. For example, the SNS can 
have a pro- or anti-inflammatory (late phase) effect (Pongratz and 
Straub, 2014; Strong et al., 2018). Therefore, neuronal pathways can use 
the same neurotransmitters either synergistically or antagonistically 
(Tracey, 2009). These observations also show the complexity of the 
system. In our opinion, the therapeutic manipulation of only one cell 
type (e. g. by receptor blockers) as a linear, reductionist intervention can 
only be associated with disadvantages and side effects (as experience has 
shown), since the cell type in question is protective under physiological 
conditions and only causes tissue damage in the case of dysregulation 
(hyperresponsiveness) (Ji et al., 2016). By contrast, the regulation of the 
ANS by means of short term SGB has an influence on cytokines and 
chemokines, for example, and – since regulation is used instead of 
suppression – has no adverse effects on the “physiological” performance 
of the inflammatory and immune system. 
For this reason, the temporary shutdown by means of SGB is a logical 
intervention, since SGB has an influence at several places at the same 
time, and the system has the chance to reorganize itself afterwards 
(autoregulation) which is typical for a complex, nonlinear system. 
5.2. Pre-existing conditions strain the neuroimmune system 
We put forward the idea that with the hyperresponsiveness of the 
immune and inflammatory system, an overreaction of the already pre-
loaded ANS plays an important role, specifically, by activity-enhancing 
positive feedback loops (see Section 3.2). So, the “cytokine storm” is 
caused by a “sympathetic storm” (Lemke, 2004) in the pre-loaded ANS; 
the “setpoint” (Tracey, 2002, 2009) is shifted, corresponding to Sper-
anski’s (1950) “first strike” (see Section 3.2). 
Thus, pre-existing sympathetic hyperactivity (including hyperten-
sion, obesity, psychological stress, multimorbidity, polymedication, 
metabolic syndrome, diabetes, intestinal diseases) and the associated 
central and peripheral neuroimmunological imbalance can lead to se-
vere, sometimes fatal processes in case of a “second strike” (see Section 
3.2) as in a viral infection with Covid-19 (Bellinvia et al., 2020) espe-
cially in older people, in whom the neuroimmonological system appears 
to be less adaptable. 
Hypertension and obesity are two major recognized risk factors for a 
severe course of Covid-19, both of which are characterized by sympa-
thetic hyperactivity and imbalance of the SNS and vagus, respectively. 
As a result, the release of leptins from adipocytes is increased (Wang 
et al., 2013). Leptins cause endothelial dysfunction with increased 
release of endothelin, and further increase in blood pressure via the SNS 
(Wang et al., 2013) (see Section 3.3). Also, central mechanisms play a 
role: Kumagai et al. (2012) describe the importance of RVLM (rostral 
ventrolateral medulla) in determining efferent sympathetic nerve ac-
tivity and blood pressure. In this way, analogous to chaos theory, further 
interdependent positive feedback loops, mediated via the SNS, are 
created. These effects are neutralized by sympathetic denervation 
(Wang et al., 2013) (which corresponds to repeatedly administered SGBs 
[Leriche and Fontaine, 1934]). 
5.3. Vagus nerve stimulation or stellate ganglion block? 
The imbalance between the SNS and the vagus with sympathetic 
hyperactivity may be an important factor in hyperinflammation with 
cytokine storm. The balance can in principle be improved by vagus 
nerve stimulation (VNS) or by SGB. Piedimonte et al. (1999) and King 
et al. (2001) considered early on in their therapeutic considerations the 
neuronal regulation of neurogenic inflammation in viral infections. 
Neuromodulation by VNS in reflex inflammation is proposed by various 
authors (Borovikova et al., 2000; Tracey, 2002; Tracey, 2009; Ji et al., 
2016; Breit et al., 2018; Caravaca et al., 2019; Pavlov and Tracey, 2015; 
Pavlov et al., 2020; Tsaava et al., 2020). Tracey (2002, 2009) suspects 
that in the future, further neuroimmunological reflex pathways will be 
discovered which can produce homeostasis in the innate and the adap-
tive immune system through therapy of the ANS. In general, according 
to these authors, it should be possible in the future to treat the immune 
response and the progression of the inflammation therapeutically via the 
neuronal networks. Caravaca et al. (2019) see the therapeutic potential 
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of the VNS also for autoimmune diseases with hyperinflammation such 
as chronic inflammatory intestinal diseases, rheumatoid arthritis, etc. 
By applying SGB we regulate not only the SNS, but also the vagus 
nerve because, on the one hand, of their close connections within the 
periphery (anatomical and rami communicantes), as we described in our 
review (Puente de la Vega Costa et al., 2016), on the other hand, indi-
rectly, because of the involvement of the sensory vagus “receiving site” 
in the brain (nucleus tractus solitarius). In addition, SGB enables us to 
reach the central sympathetic “output” centers such as the hypothala-
mus, pituitary gland, RVLM, etc. as well as peripheral sympathetic ef-
ferents and sensory fibers in the truncus sympathicus. Therefore, from a 
pathophysiological point of view, we consider SGB more advantageous 
than VNS, also confirmed experimentally by Liu et al. (2017). 
5.4. Why has the SGB not been used more frequently in medicine? 
The most common uses of SGB are in CRPS, circulatory disorders, 
and sympathetically maintained pain. The fear of hemodynamic prob-
lems has been a topic for decades. However, we could show that the 
hemodynamic parameters hardly change (Puente de la Vega Costa et al., 
2016). There is a respect for other complications. They mainly occurred 
when applying old techniques with significantly larger amounts of long- 
acting LA with a high diffusion capacity (undesired diffusion to neigh-
boring structures). With the short-acting, only slightly diffusing pro-
caine in lower amounts, we have not seen any complications; only a few 
have been noted in the literature (Fischer et al., 2005; Fischer et al., 
2010) – with the reservation that certainly not all complications have 
been reported and published. 
The decades-long fear of the allergic potential of procaine has not 
been confirmed in recent years (Fischer et al., 2005; Barop, 2017). In the 
past, mainly the additives triggered allergies. Procaine even has an anti- 
allergic potency (Barop, 2017; Fischer, 2019). 
Another reason for the limited breadth of its application is that SGB is 
not considered guideline-compliant for most indications – and usually 
only specially trained anesthetists perform SGBs. 
In addition, the range of indications is not known to many clinically 
active physicians due to decades of neglect of the ANS in pain, immune 
and inflammatory processes. 
Oyama and Node (2014) put it aptly: “Most of the previous studies 
lacked careful consideration of the impact of the ANS. The main reason 
is the difficulty to evaluate sympathetic nerve activity directly and 
easily.” 
5.5. Limitations and factors that may impair the efficacy of a stellate 
ganglion block 
Whether the injection can be performed during anticoagulation has to 
be decided individually (risk-benefit assessment, lack of other therapeutic 
options, or these have been exhausted). However, the area of injection can 
well be compressed manually after the (atraumatic) injection, preventing 
hematoma. Nevertheless, we principally advise against SGB in anti-
coagulated patients. This is another reason why early recognition of a 
threatening course of Covid-19 is important; thus, SGB can be performed 
shortly before anticoagulation is started. Therefore, clinical and laboratory 
monitoring of high-risk patients should be close-meshed. 
The timing of SGB plays a major role: it should be as early as possible, if 
laboratory or clinical evidence (e. g. beginning respiratory insufficiency) 
shows that the neuroimmunological networks are overreacting (Burke 
et al., 2020; Caricchio et al., 2021). In general, we have seen the best results 
in acute or acutely exacerbated inflammation (Pfister and Fischer, 2009; 
Schaible and Straub, 2014; Strong et al., 2018) (for “timing” see also Sec-
tion 3.5.2). 
In our experience, corticosteroids or other inhibitory drugs as well as 
old age can impede the self-organization expected after SGB (Barop, 
2017; Fischer, 2019). 
The correct technique plays an important role: not only the 
equilateral Horner symptom complex should be positively checked, but 
also a temperature increase of the equilateral upper extremity of >0.5 
◦C; because if the SNS is blocked cranially the SG, a Horner symptom 
complex is though created, but the postganglionic fibers for the lungs 
and heart are not directly affected by the block. 
In previous studies and experiments, SGB was usually only con-
ducted unilaterally. However, we propose the bilateral SGB with a time 
interval (see Section 4). 
Another limiting factor could be old age (reduced capacity for self- 
organization) – we got this impression during our clinical work – but 
this would still have to be verified by means of studies. 
6. Conclusions 
The sympathetically maintained interdependent positive feedback 
loops give the neuroimmune system an iterative, nonlinear character 
(compatible with the mathematical chaos theory). Such systems have 
the fundamental ability to reorganize themselves (autoregulation) after 
changes of state e. g. by means of SGB. With this regulation the 
nonlinearity of the system is respected. 
Previous clinical and experimental data show that the repeated, 
temporary SGB with LA procaine, is capable to regulate the sympathetic- 
triggered neurogenic inflammation processes. 
Because of the very low material costs, this therapy is also suitable 
for countries with low financial resources in the health system. 
Despite the existence of clinical and experimental data on the effect 
of SGB and its logical mechanisms of action, larger studies are necessary. 
We hope that this work will serve as a basis for applications to the ethics 
committees. 
Because of the lack of direct measurements of the ANS especially in 
pain, immune and inflammatory processes, the ANS was not considered 
enough in the past in our opinion. We hope that our conceptual view 
with partially new pathophysiological inputs may help to show how 
important the careful consideration of the ANS is. We also think that the 
therapy by the ANS is just at the beginning and that there is still a great 
potential here. 
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